Sanofi (SNY) Current Taxes (2015 - 2026)

Sanofi has disclosed Current Taxes across 12 years of filings, most recently posting $1.0 billion for Q2 2026.

• In Q2 2026, Current Taxes rose 25.38% year-over-year to $1.0 billion; the TTM figure through Jun 2026 stood at $1.0 billion (up 25.38% YoY), while the FY2025 annual figure was $874.2 million, up 15.88% from the prior year.
• Current Taxes came in at $1.0 billion for Q2 2026 at Sanofi, up from $874.2 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $1.0 billion in Q2 2026 to a low of $142.1 million in Q2 2024.
• Average Current Taxes over 5 years is $635.5 million, with a median of $642.3 million recorded in 2023.
• Year-over-year, Current Taxes tumbled 65.37% in 2024 and jumped 476.53% in 2025.
• Over 5 years, Current Taxes stood at $585.6 million in 2022, then grew by 9.68% to $642.3 million in 2023, then grew by 15.95% to $744.8 million in 2024, then grew by 17.37% to $874.2 million in 2025, then increased by 17.54% to $1.0 billion in 2026.
• Per Business Quant data, the three most recent Current Taxes figures were $1.0 billion in Q2 2026, $874.2 million in Q4 2025, and $819.5 million in Q2 2025.